CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 67,834	$ 42,694
Restricted cash	3,075	3,075
Patient accounts receivable	293,579	274,961
Prepaid expenses	17,221	10,356
Other current assets	10,776	25,598
Total current assets	392,485	356,684
Property and equipment, net of accumulated depreciation of $98,573 and $96,937	17,295	18,435
Operating lease right of use assets	102,801	101,257
Goodwill	1,204,638	1,196,090
Intangible assets, net of accumulated amortization of $18,590 and $19,900	106,534	111,190
Deferred income tax assets	0	289
Other assets	84,639	73,023
Total assets	1,908,392	1,856,968
Current liabilities:
Accounts payable	36,621	38,217
Payroll and employee benefits	151,279	141,001
Accrued expenses	148,044	150,836
Current portion of long-term obligations	12,309	12,995
Current portion of operating lease liabilities	31,901	31,233
Total current liabilities	380,154	374,282
Long-term obligations, less current portion	429,453	432,075
Operating lease liabilities, less current portion	70,295	69,309
Deferred income tax liabilities	2,915	0
Other long-term obligations	4,923	4,979
Total liabilities	887,740	880,645
Commitments and Contingencies—Note 6
Equity:
Preferred stock, $0.001 par value, 5,000,000 shares authorized; none issued or outstanding	0	0
Common stock, $0.001 par value, 60,000,000 shares authorized; 37,763,705 and 37,674,868 shares issued; and 32,566,636 and 32,509,969 shares outstanding	38	38
Additional paid-in capital	736,536	728,118
Treasury stock, at cost 5,197,069 and 5,164,899 shares of common stock	(440,550)	(435,868)
Retained earnings	670,734	639,063
Total Amedisys, Inc. stockholders’ equity	966,758	931,351
Noncontrolling interests	53,894	44,972
Total equity	1,020,652	976,323
Total liabilities and equity	$ 1,908,392	$ 1,856,968